Swiss Quality
Welcome to the Lugaia Newsroom – your source for the latest updates on our containment solutions, single-use technologies, and company developments. Here you’ll find news about new products, successful projects, partnerships, and industry events. Discover how Lugaia supports safe, efficient processes across the pharmaceutical, biotech, and chemical sectors.
Lugaia Aussenaufnahmen Gebäude Raron Standort
In 2026, Lugaia AG looks back on 20 years of successful business operations. What began two decades ago in Upper Valais has evolved into an internationally active company providing flexible containment solutions for the pharmaceutical, biotech and chemical industries.
The biopharmaceutical industry is advancing rapidly into highly potent therapies - especially antibody-drug conjugates (ADCs) - which bring unique challenges for manufacturing, containment and operator safety. At Lugaia, we understand that meeting these challenges requires top-class containment strategies, such as OEB-6 classification and double‐containment systems, combined with flexible single-use and customized solutions. This article explains why OEB-6 and double-containment matter in ADC manufacturing, what to look for and how Lugaia’s solutions support safe, efficient operations.
The year 2026 once again offers numerous international trade fair and event highlights for the pharmaceutical and process industries. Lugaia will be there again this year – meet us live on site and discover our latest solutions for containment, powder handling and safe pharmaceutical processes.
We are on company holidays from 19 December to 5 January 2026.
With the SafeSeal DuoPro, Lugaia expands its portfolio of containment solutions with an innovative 2-in-1 tool. Specially developed for use in isolators and cleanrooms, it combines crimping and cutting in a single device. Delivering GMP-compliant seals and meeting the strictest OEB-5 containment requirements (<1 µg/m³), the SafeSeal DuoPro ensures maximum safety when handling highly potent active pharmaceutical ingredients (HPAPIs) – protecting operators, products, and the environment.
Our new Sales Manager answered ten personal questions about the company, his role and ambitions for the future.
POWTECH is the leading trade fair for mechanical process engineering, analytics, and the handling of powders and bulk materials. This year, Lugaia will once again be on site – with special highlights. In addition to our comprehensive product portfolio, we are excited to present two brand-new innovations that set new benchmarks in single-use containment.
In 2015, Lugaia established its German branch in Ingolstadt, near Munich. Since then, under the leadership of Thomas Weingartner, Lugaia Deutschland GmbH has continuously evolved and made significant contributions to Lugaia's international success.
To mark the 10-year anniversary, we reflect with Thomas Weingartner on the beginnings, challenges, and achievements of the past decade and discuss the future prospects of the German branch.
Our project engineer answered ten personal questions about the company, his work and his ambitions for the future.
Ingenus Pharmaceuticals GmbH specializes in the production of cytotoxic, liquid, and lyophilic pharmaceutical products. Known for its dedication to quality and safety, the company continuously seeks innovative solutions to enhance its manufacturing processes. In its pursuit of operational excellence, Ingenus recently replaced its fixed isolator system with a flexible isolator solution from Lugaia. This switch has brought tangible improvements in flexibility, efficiency, and safety.
